Article citationsMore>>

Petrof, E.O., Gloor, G.B., Vanner, S.J., Weese, S.J., Carter, D., Daigneault, M.C., Brown, E.M., Schroeter, K. and Allen-Vercoe, E. (2013) Stool Substitute Transplant Therapy for the Eradication of Clostridium difficile Infection: “RePOOPulating” the Gut. Microbiome, 1, 3.
http://dx.doi.org/10.1186/2049-2618-1-3

has been cited by the following article:

• TITLE: Inflammatory Bowel Diseases: What Do We Still Need to Investigate?

  AUTHORS: Marina Taus, Debora Busni, Daniele Fumelli, Arianna Paci, Giulia Nicolai, Albano Nicolai

  KEYWORDS: Inflammatory Bowel Desease, Fecal Mass Transplantation, Nutrition and Macrobiota

  JOURNAL NAME: Open Journal of Gastroenterology, Vol.5 No.10, October 28, 2015

  ABSTRACT: Inflammatory bowel disease (IBD) including Crohn (CD) and ulcerative colitis (UC), is intestinal disorders with an unknown specific etiology. Many factors are involved in the pathogenesis: genetic, environment, nutrition, immunity and intestinal dysbiosis. In the present work, we review the most important trigger mechanisms involved in IBD, with a particular regard to the role of microbiota and fecal mass transplantation as a new therapeutic approach, that even if it can be considered safe and effective, data are necessary regarding all procedures not yet standardized and timing of treatment.